...
首页> 外文期刊>African journal of urology >Ameliorative potential of gemfibrozil and silymarin on experimentally induced nephrotoxicity in rats
【24h】

Ameliorative potential of gemfibrozil and silymarin on experimentally induced nephrotoxicity in rats

机译:吉非贝齐和水飞蓟素对大鼠实验性肾毒性的改善作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Introduction Acute nephrotoxicity is a frequent complication of critical illness especially in the inpatient setting. Cisplatin is one of the most active anticancer drugs. Nephrotoxicity is the most common side effect associated with cisplatin treatment. Silymarin is widely used for hepatic disorders due to its antioxidant and anti-inflammatory properties. Gemfibrozil, a hypolipidemic drug, has also antioxidant and anti-inflammatory properties. Objective To detect the effect of gemfibrozil and silymarin either alone or in combination on cisplatin-induced nephrotoxicity in rats. Subjects and methods Fifty albino rats were divided into 5 equal groups: Control untreated group, cisplatin treated group, gemfibrozil + cisplatin treated group, silymarin + cisplatin treated group, gemfibrozil + silymarin + cisplatin treated group. Blood urea, serum creatinine, creatinine clearance, urinary N-acetyl beta- d -glucosaminidase, urinary protein, tissue superoxide dismutase, malondialdehyde, reduced glutathione, tumour necrosis factor alpha and mitochondrial complex I activity were determined. Kidneys were excised for histopathological examination. Results Gemfibrozil and/or silymarin efficiently attenuated cisplatin-induced nephrotoxicity evidenced by significant decrease in blood urea, serum creatinine, urinary N-acetyl beta- d -glucosaminidase, urinary protein, tissue malondialdehyde and tissue tumour necrosis factor alpha with significant increase in creatinine clearance, tissue reduced glutathione, tissue superoxide dismutase and mitochondrial complex I activity simultaneous with reduction of the necrotic damage and progressively increasing apoptotic index assessed by renal histopathological examination compared to the cisplatin treated group. Conclusion The combination of gemfibrozil and silymarin has protective effects against cisplatin-induced nephrotoxicity in rats better than each of these drugs alone due to anti-inflammatory and antioxidant properties of the used drugs.
机译:简介急性肾毒性是严重疾病的常见并发症,尤其是在住院患者中。顺铂是最活跃的抗癌药物之一。肾毒性是与顺铂治疗相关的最常见的副作用。水飞蓟素因其抗氧化和抗炎特性而被广泛用于肝病。 Gemfibrozil,一种降血脂药,也具有抗氧化和抗炎特性。目的探讨吉非贝齐和水飞蓟素单独或联合使用对顺铂致大鼠肾毒性的作用。受试者和方法将50只白化病大鼠分为5组,分别为空白对照组,顺铂治疗组,吉非贝齐+顺铂治疗组,水飞蓟素+顺铂治疗组,吉非贝齐+水飞蓟素+顺铂治疗组。测定血尿素,血清肌酐,肌酐清除率,尿N-乙酰基β-d-氨基葡萄糖苷酶,尿蛋白,组织超氧化物歧化酶,丙二醛,还原型谷胱甘肽,肿瘤坏死因子α和线粒体复合体I活性。切除肾脏以进行组织病理学检查。结果吉非贝齐和/或水飞蓟素有效减轻了顺铂诱导的肾毒性,其表现为血尿素,血清肌酐,尿液中的N-乙酰基β-d-氨基葡萄糖苷酶,尿蛋白,组织丙二醛和组织肿瘤坏死因子α显着降低,肌酐清除率显着提高与顺铂治疗组相比,通过肾脏组织病理学检查评估,组织减少的谷胱甘肽,组织超氧化物歧化酶和线粒体复合体I活性同时减少了坏死性损害并逐渐增加了凋亡指数。结论吉非贝齐和水飞蓟素的联合用药具有抗炎和抗氧化的作用,对顺铂引起的大鼠肾毒性具有更好的保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号